
c/side: The Client-Side Platform for Cybersecurity, Compliance, and Privacy
Monitoring third-party scripts effectively eliminates uncertainty, ensuring that you are always aware of what is being delivered to your users' browsers, while also enhancing script performance by up to 30%. The unchecked presence of these scripts in users' browsers can lead to significant issues when things go awry, resulting in adverse publicity, potential legal actions, and claims for damages stemming from security breaches. Compliance with PCI DSS 4.0.1, particularly sections 6.4.3 and 11.6.1, requires that organizations handling cardholder data implement tamper-detection measures by March 31, 2025, to help prevent attacks by notifying stakeholders of unauthorized modifications to HTTP headers and payment information. c/side stands out as the sole fully autonomous detection solution dedicated to evaluating third-party scripts, moving beyond reliance on merely threat feed intelligence or easily bypassed detections. By leveraging historical data and artificial intelligence, c/side meticulously analyzes the payloads and behaviors of scripts, ensuring a proactive stance against emerging threats. Our continuous monitoring of numerous sites allows us to stay ahead of new attack vectors, as we process all scripts to refine and enhance our detection capabilities. This comprehensive approach not only safeguards your digital environment but also instills greater confidence in the security of third-party integrations.
Learn more
D&B Hoovers can help you create a more profitable relationship from prospect to client faster. Find key prospects and growth opportunities. D&B Hoovers, a sales acceleration solution, provides a faster path to prospect to profitable relationship through the use of data and analytics. B2B sales professionals can connect with customers faster to grow their businesses. Access detailed intelligence on over 120 million business records. Provide insight and intelligence into the tools that your marketers and sellers use every day. A user-friendly interface and automated workflow features, including triggers, alerts and smart lists, as well as intuitive search and conceptual search. D&B Hoovers combines Dun & Bradstreet's largest commercial database with sophisticated analytics to provide a rich sales intelligence solution. D&B Hoovers provides dynamic search and list-building capabilities as well as realtime trigger alerts, detailed company profiles and valuable research reports.
Learn more
Spotlight.ai
Spotlight.ai serves as a cutting-edge, autonomous platform for executing deals, effectively converting sales pipelines into self-managing revenue systems by capturing, evaluating, and moving forward with each opportunity without the necessity for human oversight. This innovative tool listens to and extracts organized information from various communication channels including calls on platforms like Zoom and Teams, emails, and entries from CRM systems; it also verifies the status of deals and assesses associated risks while performing a comprehensive MEDDICC qualification to pinpoint key stakeholders such as champions and economic buyers. The AI-driven agents within the platform create data-supported business cases, presentation decks, and actionable next steps, seamlessly integrating precise, metrics-based updates into Salesforce while conducting effortless deal reviews that feature predictive analytics and key performance indicators. By consistently mapping the interconnections between pipeline actions, deal information, and team contributions, Spotlight.ai ensures optimal data integrity, automates the progression of opportunities through various stages, and identifies significant gaps that sales representatives need to address, ultimately enhancing overall efficiency and effectiveness in the sales process. This level of automation not only streamlines workflows but also empowers teams to focus on strategic decision-making and relationship-building, driving greater success in closing deals.
Learn more
SignalPGx
SignalPGx serves as a worldwide platform for pharmacogenomics reporting and medication intelligence, catering to laboratories, hospital systems, provider networks, clinics, pharmacy partners, and healthcare organizations. This innovative platform transforms genotype data into medication guidance that is both physician-reviewed and supported by evidence, utilizing white-label PGx reports, SignalAI-assisted interpretation, a Medication Intelligence Graph, Living Patient Passport, medication simulation, and continuous reanalysis.
The system is compatible with various file formats, including VCF, Agena MassARRAY, CSV, and custom lab files, and offers EHR-ready integrations such as SMART on FHIR, HL7/FHIR, CDS Hooks, and REST APIs. Designed for enterprise-level healthcare implementation, SignalPGx features tenant isolation, role-based access control, audit logging, encryption, and a scalable multi-region infrastructure hosted on AWS, ensuring that healthcare providers can rely on it for comprehensive medication management. Furthermore, its robust architecture guarantees seamless operation and data security for all users, enhancing the overall efficiency of healthcare delivery.
Learn more